Drug-induced Lung Disease Associated With Ustekinumab in a Pediatric Patient With Crohn Disease

J Pediatr Gastroenterol Nutr. 2020 Nov;71(5):e143-e145. doi: 10.1097/MPG.0000000000002783.

Authors

Elana B Mitchel¹, Adam Paul², Alexander El-Ali³, Pi Chun Cheng⁴, Lindsey G Albenberg¹

Affiliations

¹ Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia.
² Division of Gastroenterology and Nutrition, Lehigh valley Reilly Children's Hospital, Allentown.
³ Division of Pediatric Radiology.
⁴ Division of Pulmonary Medicine, Children's Hospital of Philadelphia, Philadelphia, PA.

PMID: 33093382
DOI: 10.1097/MPG.0000000000002783

No abstract available

MeSH terms

Child
Crohn Disease* / drug therapy
Humans
Lung Diseases*
Pharmaceutical Preparations*
Ustekinumab / adverse effects

Substances

Pharmaceutical Preparations
Ustekinumab